Xconomy National

Archives

by in
Entry Author Date Location
Xconomist of the Week: Stephen Wolfram on Big Ideas & Companies Gregory T. Huang 12/08/11 Boston
Allozyne Acquires Poniard Pharmaceuticals, Finds Backdoor Route to NASDAQ Luke Timmerman 06/22/11 Seattle
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News Luke Timmerman 03/24/11 Seattle
Allen Institute Adds Caltech Neuroscientist Luke Timmerman 03/22/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort Luke Timmerman 02/15/11 Seattle
Computing in the Age of the $1,000 Genome: Speakers from Isilon, Arch Join Stellar Lineup Luke Timmerman 12/27/10 Seattle
NanoString Scoops Up Breast Cancer Technology, Pushes Ahead in Diagnostics Luke Timmerman 12/06/10 Seattle
Paul Allen Donates $9M for Edgy Neuroscience, Biotech Projects at MIT, Stanford, UW Luke Timmerman 11/18/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster Luke Timmerman 10/26/10 Seattle
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs Ryan McBride 09/07/10 Boston
Illumina Acquires Helixis for Up to $105M, To Get Small, Low-Cost Genetic Analysis Tool Luke Timmerman 07/27/10 San Diego
Immune Design Follows Corixa Playbook, Sees Data, Deals on the Horizon in Year Three Luke Timmerman 07/27/10 Seattle
Integrated Diagnostics, Leroy Hood’s Latest Startup, Pockets $10M After Hitting Early Goals Luke Timmerman 07/22/10 Seattle
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline Luke Timmerman 07/14/10 Seattle
NanoString Hires Genzyme Vet as CEO to Lead Foray Into Molecular Diagnostics Luke Timmerman 06/29/10 Seattle
Reg Kelly, Scotsman from Humble Roots, Finds New Purpose at QB3 in Mission Bay Luke Timmerman 06/21/10 San Francisco
Scripps Chemistry Idea “Clicks” With Big Pharma, Seattle’s Integrated Diagnostics Luke Timmerman 05/19/10 San Diego
Technology Alliance Showcases Five Companies in Sensors, Mobile Displays, and Drug Therapies: Investors Take Notice Gregory T. Huang 04/22/10 Seattle
Selecta Biosciences, a Bob Langer Creation, Raises $15M For Nanoparticle Vaccines Luke Timmerman 04/05/10 Boston
Lee Hood’s Startup for Personalized Medicine, Integrated Diagnostics, Hires First CEO Luke Timmerman 03/29/10 Seattle
Nathan Myhrvold, Lee Hood Forge Longstanding Partnership at Nexus of IT and Biology Luke Timmerman 03/24/10 Seattle
NanoString Chairman Bill Young Scopes Out Diagnostic Future, Considers Bay Area Expansion Luke Timmerman 02/19/10 Seattle
Helixis, Like PC Firms of Old, Putting “Desktop” Genetics Tools on Every Biology Bench Luke Timmerman 01/25/10 San Diego
Regulus Adds IP from Baltimore Lab Luke Timmerman 12/17/09 San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday Luke Timmerman 12/09/09 San Diego
So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design To Raise Cash Luke Timmerman 11/23/09 Seattle
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region Luke Timmerman 11/10/09 San Diego
Helixis, Caltech Spinoff With Desktop Genetic Analysis Tool, Nabs $7.3M Venture Financing Luke Timmerman 10/27/09 San Diego
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days Luke Timmerman 10/14/09 Seattle
Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub Carl Weissman 10/01/09 Seattle
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.